Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: A pilot randomized controlled study

European Journal of Gastroenterology and Hepatology

Volumn 22, Issue 1, 2010, Pages 33-42

  Lyra, Andre Castro ^a   Soares, Milena Botelho Pereira ^b,c   Da Silva, Luiz Flavio Maia ^b   Braga, Eduardo Lorens ^a   Oliveira, Sheilla A ^c   Fortes, Marcos Fraga ^c   Silva, Andre Goyanna Pinheiro ^d   Brustolim, Daniele ^b   Genser, Bernd ^e   Dos Santos, Ricardo Ribeiro ^b,c   Lyra, Luiz Guilherme Costa ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b Hospital Sao Rafael Medicine Hematology   (Israel)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d HOSPITAL SÃO RAFAEL   (Brazil)

^e BGStats Consulting   (Austria)

Author keywords

Bone marrow stem cell transplantation; CD34 +; Cell therapy; Chronic liver disease; Cirrhosis

Indexed keywords

ADEFOVIR; ALBUMIN; BILIRUBIN; LAMIVUDINE;

ADULT; AGE DISTRIBUTION; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; AUTOTRANSPLANTATION; BILIRUBIN BLOOD LEVEL; BONE MARROW CELL; BONE MARROW MONONUCLEAR CELL TRANSPLANTATION; CELL TRANSPLANTATION; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEPATIC ARTERY; HEPATITIS B; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; THERAPY EFFECT;

ADOLESCENT; ADULT; AGED; BILIRUBIN; BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; EPIDEMIOLOGIC METHODS; FEMALE; HEPATIC ARTERY; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROTHROMBIN TIME; SERUM ALBUMIN; WAITING LISTS; YOUNG ADULT;

EID: 74349090668     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32832eb69a     Document Type: Article

References (27)

1. Evarts RP, Nagy P, Nakatsukasa H, Marsden E, Thorgeirsson SS. In vivo differentiation of rat liver oval cells into hepatocytes. Cancer Res 1989; 49:1541-1547.
2. Tatematsu M, Ho RH, Kaku T, Ekem JK, Farber E. Studies on the proliferation and fate of oval cells in the liver of rats treated with 2-acetylaminofluorene and partial hepatectomy. Am J Pathol 1984; 114:418-430.
3. Theise ND, Badve S, Saxena R, Henegariu O, Sell S, Crawford JM, et al. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myoablation. Hepatology 2000; 31:235-240.
4. Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, Dohse M, Osborne L, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nature Med 2000; 6:1229-1234.
5. Lé vesque JP, Winkler IG, Larsen SR, Rasko JE. Mobilization of bone marrow-derived progenitors. Handb Exp Pharmacol 2007; 180:3-36.
6. Forbes SJ, Russo FP, Rey V, Burra P, Rugge M, Wright NW, et al. A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 2004; 126:955-963.
7. Kallis YN, Alison MR, Forbes SJ. Bone marrow stem cells and liver disease. Gut 2007; 56:716-724.
8. Thorgeirsson SS, Grisham JW. Hematopoietic cells as hepatocyte stem cells: a critical review of the evidence. Hepatology 2006; 43:2-8.
9. Yannaki E, Athanasiou E, Xagorari A, Constantinou V, Batsis I, Kaloyannidis P, et al. G-CSF-primed hematopoietic stem cells or G-CSF per se acelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs. Exp Hematol 2005; 35:108-119.
10. Fang B, Shi M, Liao L, Yang S, Liu Y, Zhao RC. Systemic infusion of FLK1( + ) mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice. Transplantation 2004; 78:83-88.
11. Sakaida I, Terai S, Nishina H, Okita K. Development of cell therapy using autologous bone marrow cells for liver cirrhosis. Med Mol Morphol 2005; 38:197-202. (Pubitemid 351543861)
12. Sakaida I, Terai S, Yamamoto N, Aoyama K, Ishikawa T, Nishina H, Okita K. Transplantation of bone marrow cells reduces CCl4-induced liver fi brosis in mice. Hepatology 2004; 40:1304-1311.
13. Allen KJ, Cheah DMY, Lee XL, Pettigrew-Buck NE, Vadolas J, Mercer JFB, et al. The potential of bone marrow stem cells to correct liver dysfunction in a mouse model of Wilson's disease. Cell Transplant 2004; 13:765-773.
14. Gaia S, Smedile A, Omede P, Olivero A, Sanavio F, Balzola F, et al. Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. J Hepatol 2006; 45:13-19.
15. Gordon MY, Levicar N, Pai M, Bachellier P, Dimarakis I, Al-Allaf F, et al. Characterization and clinical application of human CD34 + stem/progenitor cell populations mobilized into the blood by granulocyte colonystimulating factor. Stem Cells 2006; 24:1822-1830.
16. Lyra AC, Soares MB, da Silva LF, Fortes MF, Silva AG, Mota AC, et al. Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease. World J Gastroenterol 2007; 13:1067-1073.
17. Terai S, Ishikawa T, Omori K, Aoyama K, Marumoto Y, Urata Y, et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 2006; 24:2292-2298.
18. Terai S, Segawa M, Omori K, Takuya I, Mizunaga Y, Matsumoto T, et al. Long time follow up for the patient of autologous bone marrow cell infusion (ABMI) therapy for liver cirrhosis. Hepatology 2007; 46 (Suppl 1):246A.
19. Levicar N, Pai M, Habib NA, Tait P, Jiao LR, Marley SB, et al. Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34 + cells in patients with chronic liver disease. Cell Prolif 2008; 41 (Suppl 1):115-125.
20. Ahrar K, Gupta S. Hepatic artery embolization for hepatocellular carcinoma: technique, patient selection, and outcomes. Surg Oncol Clin N Am 2003; 12:105-126.
21. Houlihan DD, Newsome PN. Critical review of clinical trials of bone marrow stem cells in liver disease. Gastroenterology 2008; 135:438-450.
22. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006; 355:1199-1209.
23. Schächinger V, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Hölschermann H, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006; 355:1210-1221.
24. Assmus B, Fischer-Rasokat U, Honold J, Seeger FH, Fichtlscherer S, Tonn T, et al. Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry. Circ Res 2007; 100:1234-1241.
25. Lunde K, Solheim S, Aakhus S, Arnesen H, Moum T, Abdelnoor M, et al. Exercise capacity and quality of life after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: results from the Autologous Stem cell Transplantation in Acute Myocardial Infarction (ASTAMI) randomized controlled trial. Am Heart J 2007; 154:710.e1-710.e8.
26. Vilas-Boas F, Feitosa GS, Soares MB, Pinho-Filho JA, Mota A, Almeida AJ, et al. Bone marrow cell transplantation to the myocardium of a patient with heart failure due to Chagas' disease. Arq Bras Cardiol 2004; 82:185-187.
27. Lyra AC, Soares MB, dos Santos RR, Lyra LG. Bone marrow stem cells and liver disease. Gut 2007; 56:1640.